• No results found

medroxyprogesterone acetate (MPA)

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib

... FTS, MPA, FTS + MPA (concentrations as in ...while MPA caused a decrease in total ERα in USPC1 cells but not in the phosphorylated ...not MPA, downregulates pathways of active Ras ...acid; ...

13

Conservative Medroxyprogesterone Acetate Therapy in Early Stage of Endometrial Carcinoma Associated with Phosphatase and Tensin Homolog Expression

Conservative Medroxyprogesterone Acetate Therapy in Early Stage of Endometrial Carcinoma Associated with Phosphatase and Tensin Homolog Expression

... with medroxyprogesterone acetate (MPA, 400 - 600 mg/day) for 4 - 10 months, with whole wall endometrial curettage performed every four ...before MPA treatment (8/10) was significant better ...

13

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

... versus MPA concentrations ...or MPA for 6 hours in triplicate, time-sepa- rated ...all MPA- and progesterone-regulated ...dihydrotestosterone; MPA, medroxyprogesterone acetate; ...

15

Development of Immunochemical Methods for Purification and Detection of the Steroid Drug Medroxyprogesterone Acetate

Development of Immunochemical Methods for Purification and Detection of the Steroid Drug Medroxyprogesterone Acetate

... and medroxyprogesterone acetate (MPA, Figure 1(a)), which are the main components of contraceptive drugs and are also used as anabolic steroids; a representative non- steroid anti-inflammatory drug ...

16

Formulation development and evaluation of medroxyprogesterone acetate injectable suspension

Formulation development and evaluation of medroxyprogesterone acetate injectable suspension

... The aim of the present work is to develop sustained release parenteral drug delivery system of contraceptive drug i., e medroxyprogesterone acetate. The formulation was prepared by sterile combining of API ...

6

Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa

Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa

... depot medroxyprogesterone acetate (DMPA) and norethister- one oenanthate (NET-EN) are by far the most widely uti- lised contraceptives in South Africa, especially amongst younger users and women living in ...

9

Endocrine and Ovarian Changes in Response to the Ram Effect in Medroxyprogesterone Acetate-primed Corriedale Ewes During the Breeding and Nonbreeding Season

Endocrine and Ovarian Changes in Response to the Ram Effect in Medroxyprogesterone Acetate-primed Corriedale Ewes During the Breeding and Nonbreeding Season

... in medroxyprogesterone acetate-primed corriedale ewes during the breeding and ...in medroxyprogesterone acetate (MAP)-primed ewes after ram ...

12

Review of Contraception with Depot Medroxyprogesterone Acetate at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria

Review of Contraception with Depot Medroxyprogesterone Acetate at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria

... depot medroxyprogesterone acetate at the UPTH were retrieved and their data including the socio- demographic characteristics, side effects, reasons for family planning extracted, coded and entered into a ...

6

Trace Elements Levels and Blood Pressure in Ghanaian Women Using Depot Medroxyprogesterone Acetate Contraceptive

Trace Elements Levels and Blood Pressure in Ghanaian Women Using Depot Medroxyprogesterone Acetate Contraceptive

... The contraceptive, depot medroxyprogesterone acetate (DMPA) has played a very important role in birth control over the past few decades. It has proven to be a reliable contraceptive with it failure rate ...

7

High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception

High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception

... Depot medroxyprogesterone acetate users may differ from users of other methods or from non-contraceptors be- cause DMPA is a simple-to-use method well-suited to women with busy schedules, chaotic lives, or ...

6

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery

... Contraceptive counseling for reproductive-age women after bariatric surgery is still an area of ambiguity for obstetrician/gynecologists and bariatric surgeons alike. Although it is recommended that women avoid pregnancy ...

8

A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral Contraceptive Pill as Contraception

A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral Contraceptive Pill as Contraception

... (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant. Services[r] ...

10

Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells

Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells

... facilitate ER-associated degradation to eliminate misfolded proteins in the ER [25]. If UPR is insufficient to alleviate the stress, it then leads to cell death [24]. Previous study has demonstrated that ER stress ...

11

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity

... for Contraceptive Options and HIV Outcomes) trial, designed to determine the impact of type of contraceptive on risk of HIV acquisition, is currently ongoing (http://echo-consortium.com). Furthermore, understanding ...

18

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem

... This study aimed to compare sexual function of women using DMPA with women using Cyclofem presented to health centers affili- ated to Shahid Beheshti University of Medical Sciences in T[r] ...

7

Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model

Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model

... [11] and toolkits to aid policymakers and practitioners in scaling up community-based access to injectables have also been produced [30-33]. By contrast, this paper seeks to synthesize e[r] ...

12

Association of intimate partner vasectomy, use of long acting progestogen based contraceptives and intra uterine contraceptive devices with risk of ovarian cancer

Association of intimate partner vasectomy, use of long acting progestogen based contraceptives and intra uterine contraceptive devices with risk of ovarian cancer

... The WHO Collaborative Study of Neoplasia and Steroid Contraceptives found no association between ever-use of depot medroxyprogesterone acetate DMPA and ovarian cancer, and showed no cons[r] ...

314

Contraception in HIV-positive female adolescents

Contraception in HIV-positive female adolescents

... medroxyprogesterone acetate; ddI: didanozine; D4T: stavudine; DRV/r: ritonavir boosted darunavir; EC: emergency contraception; EE: ethinyl estradiol; EFV: efavirenz; ETR: etravirine; FDA: US Food and Drugs ...

11

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits

... Abbreviations: CIC, combined injectable contraceptive; COC, combined oral contraceptive; DM, diabetes mellitus; DMPA, depot medroxyprogesterone acetate; DVT/PE, deep venous thrombosis/[r] ...

11

Progesterone- primed ovarian stimulation in polycystic ovarian syndrome: An RCT

Progesterone- primed ovarian stimulation in polycystic ovarian syndrome: An RCT

... Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial. R[r] ...

6

Show all 3501 documents...

Related subjects